Related Experiment Video
Updated: May 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Rationale for establishing a mechanism to increase reimbursement to hypertension specialists
William J Elliott1, Brent Egan, Thomas D Giles
1Division of Pharmacology, Pacific Northwest University of Health Sciences, Yakima, WA 98901, USA. wj.elliott@yahoo.com
Insights
Hypertension remains a significant public health issue. Increased reimbursement for care provided by American Society of Hypertension (ASH)-Designated Hypertension Specialists is proposed to improve blood pressure control.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Public Health
Background:
- Hypertension is a major global health concern, linked to cardiovascular and renal diseases.
- Despite progress, many Americans have uncontrolled blood pressure, increasing risks of stroke, heart attack, and heart failure.
- Hypertension is complex and heterogeneous, necessitating specialized care.
Purpose of the Study:
- To establish the rationale for increased reimbursement for patients receiving care from ASH-Designated Hypertension Specialists.
- To advocate for improved recognition and compensation for specialized hypertension management.
Main Methods:
- The report outlines the qualifications and expertise of ASH-Designated Hypertension Specialists.
- It highlights their proven success in managing resistant hypertension and educating peers.
- The rationale for increased reimbursement is based on their specialized skills and impact on patient outcomes.
Main Results:
- ASH-Designated Hypertension Specialists are fully licensed physicians with expertise in hypertension diagnosis and treatment.
- These specialists demonstrate success in controlling blood pressure, including in resistant cases.
- They play a role in educating other physicians to enhance blood pressure control rates.
Conclusions:
- ASH-Designated Hypertension Specialists possess unique expertise in managing complex hypertension.
- Increased reimbursement for their services is justified by their proven ability to improve patient outcomes.
- Recognizing and compensating these specialists can lead to better hypertension control nationwide.
Abstract:
Hypertension is an important public health problem both in the United States and worldwide, contributing to many forms of cardiovascular and renal diseases. Although great strides have been made in the proportion of the US population that achieves recommended blood pressure targets, many Americans still have undertreated and uncontrolled blood pressure that increases the risk of expensive strokes, heart attacks, heart failure, and dialysis. Because hypertension is a common but heterogeneous and sometimes complex condition, the American Society of Hypertension (ASH) has, since 1999, designated physicians as "ASH Hypertension Specialists." Such Hypertension Specialists (as defined by ASH's Specialist Program) are fully licensed physicians with a primary board certification who are competent in all aspects of the diagnosis and treatment of hypertension, as evidenced by passing a specific examination on these topics offered by ASH's Specialist Program. These physicians have a proven track record of controlling blood pressure in "resistant hypertensive" patients, the general population whom they serve, and educating other physicians to help them achieve higher blood pressure control rates among their patient populations. This report sets out a rationale for increased reimbursement for care of hypertensive patients by ASH-Designated Hypertension Specialists.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Errors occurring during blood pressure monitoring
Several factors...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension II: Pathophysiology
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hypertension V: Nursing Management